Company profile: Avanir Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of biopharmaceutical medicines for central nervous system disorders, focused on high unmet medical need. Offers Nuedexta, a medication used to treat pseudobulbar affect (PBA), characterized by sudden, uncontrollable episodes of crying or laughing. Extensively invests in its pipeline and is dedicated to advancing medicines that can substantially improve patients' lives.
Products and services
- CNS Medicines Pipeline Development: Engineers a CNS-focused biopharmaceutical pipeline targeting disorders with high unmet medical need, accelerating innovative medicines toward patients through extensive investment and dedicated advancement efforts
- Nuedexta: Produces a CNS-specific medication used to treat pseudobulbar affect, characterized by sudden, uncontrollable episodes of crying or laughing, supplying symptomatic control for patients with this neurological condition
- Patient CNS Therapeutics Advancement: Delivers biopharmaceutical-grade advancement of innovative medicines for central nervous system disorders, dedicated to substantially improving patients’ lives and addressing high unmet medical need across CNS conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avanir Pharmaceuticals
Neural Therapeutics
HQ: Canada
Website
- Description: Provider of ethnobotanical drug discovery, psychedelic-based therapeutics for mental health, and dietary supplements. Focuses on San Pedro cactus for mescaline-derived compounds, conducts pharma and nutraceutical R&D leveraging indigenous knowledge, develops IP with partners like Validity Labs, and establishes sustainable, legally compliant sourcing and cultivation in Peru.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neural Therapeutics company profile →
Taysha Gene Therapies
HQ: United States
Website
- Description: Provider of gene therapies targeting severe, life-threatening monogenic diseases of the central nervous system, including TSHA-102 for Rett syndrome. Services include conducting clinical trials to assess safety and efficacy, offering an expanded access program for investigational therapies, advancing gene therapy research, and providing patient affairs support and educational resources with advocacy partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Taysha Gene Therapies company profile →
Muna Therapeutics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical therapies and discovery platforms to slow or stop neurodegenerative diseases including Alzheimer’s, Parkinson’s, Frontotemporal Dementia, and Multiple Sclerosis. Programs include TREM2 agonism for early-stage Alzheimer’s, Kv1.3 blockade for Parkinson’s and MS, and MiND-MAP, an all-in-human target discovery and validation platform using single cell spatial multi-omics in patient samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Muna Therapeutics company profile →
HMNC Brain Health
HQ: Germany
Website
- Description: Provider of precision medicine in psychiatry, based in Munich, developing patented genetic tests and combining those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders; founded in 2010, this privately held biotech company develops machine learning-enabled companion diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HMNC Brain Health company profile →
Neuronetics
HQ: United States
Website
- Description: Provider of non-drug, non-invasive TMS therapies for mental health, including NeuroStar Advanced Therapy for major depressive disorder using precise magnetic stimulation, supported by the TrakStar HIPAA-compliant practice management system and features like MT Assist and Contact Sensing for accurate dosing and real-time treatment feedback.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuronetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avanir Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avanir Pharmaceuticals
2.2 - Growth funds investing in similar companies to Avanir Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avanir Pharmaceuticals
4.2 - Public trading comparable groups for Avanir Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →